460 related articles for article (PubMed ID: 22840842)
1. The NLRP12 inflammasome recognizes Yersinia pestis.
Vladimer GI; Weng D; Paquette SW; Vanaja SK; Rathinam VA; Aune MH; Conlon JE; Burbage JJ; Proulx MK; Liu Q; Reed G; Mecsas JC; Iwakura Y; Bertin J; Goguen JD; Fitzgerald KA; Lien E
Immunity; 2012 Jul; 37(1):96-107. PubMed ID: 22840842
[TBL] [Abstract][Full Text] [Related]
2. The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation.
Ratner D; Orning MP; Proulx MK; Wang D; Gavrilin MA; Wewers MD; Alnemri ES; Johnson PF; Lee B; Mecsas J; Kayagaki N; Goguen JD; Lien E
PLoS Pathog; 2016 Dec; 12(12):e1006035. PubMed ID: 27911947
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of Interleukin-1β and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence.
Ratner D; Orning MP; Starheim KK; Marty-Roix R; Proulx MK; Goguen JD; Lien E
J Biol Chem; 2016 May; 291(19):9894-905. PubMed ID: 26884330
[TBL] [Abstract][Full Text] [Related]
4. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages.
Zheng Y; Lilo S; Brodsky IE; Zhang Y; Medzhitov R; Marcu KB; Bliska JB
PLoS Pathog; 2011 Apr; 7(4):e1002026. PubMed ID: 21533069
[TBL] [Abstract][Full Text] [Related]
5. NLRP12 in innate immunity and inflammation.
Tuladhar S; Kanneganti TD
Mol Aspects Med; 2020 Dec; 76():100887. PubMed ID: 32838963
[TBL] [Abstract][Full Text] [Related]
6. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.
Dhariwala MO; Olson RM; Anderson DM
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850
[No Abstract] [Full Text] [Related]
7. Yersinia pestis evades TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cell migration.
Robinson RT; Khader SA; Locksley RM; Lien E; Smiley ST; Cooper AM
J Immunol; 2008 Oct; 181(8):5560-7. PubMed ID: 18832714
[TBL] [Abstract][Full Text] [Related]
8. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
Lin JS; Kummer LW; Szaba FM; Smiley ST
J Immunol; 2011 Feb; 186(3):1675-84. PubMed ID: 21172869
[TBL] [Abstract][Full Text] [Related]
9. A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plague.
Spear AM; Rana RR; Jenner DC; Flick-Smith HC; Oyston PCF; Simpson P; Matthews SJ; Byrne B; Atkins HS
Microbiology (Reading); 2012 Jun; 158(Pt 6):1593-1606. PubMed ID: 22403187
[TBL] [Abstract][Full Text] [Related]
10. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.
Nakajima R; Brubaker RR
Infect Immun; 1993 Jan; 61(1):23-31. PubMed ID: 8418045
[TBL] [Abstract][Full Text] [Related]
11. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.
Szaba FM; Kummer LW; Wilhelm LB; Lin JS; Parent MA; Montminy-Paquette SW; Lien E; Johnson LL; Smiley ST
Infect Immun; 2009 Oct; 77(10):4295-304. PubMed ID: 19620344
[TBL] [Abstract][Full Text] [Related]
12. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
13. NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus.
Silveira TN; Gomes MT; Oliveira LS; Campos PC; Machado GG; Oliveira SC
Eur J Immunol; 2017 Jan; 47(1):51-59. PubMed ID: 27800616
[TBL] [Abstract][Full Text] [Related]
14. Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague.
Olson RM; Dhariwala MO; Mitchell WJ; Anderson DM
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642901
[No Abstract] [Full Text] [Related]
15. The multifaceted nature of NLRP12.
Tuncer S; Fiorillo MT; Sorrentino R
J Leukoc Biol; 2014 Dec; 96(6):991-1000. PubMed ID: 25249449
[TBL] [Abstract][Full Text] [Related]
16. Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
Vagima Y; Zauberman A; Levy Y; Gur D; Tidhar A; Aftalion M; Shafferman A; Mamroud E
PLoS Pathog; 2015 May; 11(5):e1004893. PubMed ID: 25974210
[TBL] [Abstract][Full Text] [Related]
17. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
[TBL] [Abstract][Full Text] [Related]
18. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis.
Reithmeier-Rost D; Hill J; Elvin SJ; Williamson D; Dittmann S; Schmid A; Wilharm G; Sing A
Microbes Infect; 2007 Jul; 9(8):997-1002. PubMed ID: 17556003
[TBL] [Abstract][Full Text] [Related]
19. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica.
Hajjar AM; Ernst RK; Fortuno ES; Brasfield AS; Yam CS; Newlon LA; Kollmann TR; Miller SI; Wilson CB
PLoS Pathog; 2012; 8(10):e1002963. PubMed ID: 23071439
[TBL] [Abstract][Full Text] [Related]
20. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.
Nakajima R; Motin VL; Brubaker RR
Infect Immun; 1995 Aug; 63(8):3021-9. PubMed ID: 7622225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
